norethindrone acetate

FDA Drug Profile — Norethindrone acetate

norethindrone acetate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Norethindrone acetate. Available dosage form: tablet.

Drug details

Generic Name
norethindrone acetate
Brand Names
Norethindrone acetate
Application Number
ANDA206490
Sponsor
Ingenus Pharmaceuticals, LLC
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
NORETHINDRONE ACETATE

Indications and Usage

INDICATIONS AND USAGE Norethindrone acetate is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer. Norethindrone acetate is not intended, recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection.

Warnings

WARNINGS 1. Cardiovascular disorders Patients with risk factors for arterial vascular disease (e.g., hypertension, diabetes mellitus, tobacco use, hypercholesterolemia, and obesity) and/or venous thromboembolism (e.g., personal history or family history of VTE, obesity, and systemic lupus erythematosus) should be managed appropriately. 2. Visual abnormalities Discontinue medication pending examination if there is a sudden partial or complete loss of vision or if there is sudden onset of proptosis, diplopia, or migraine. If examination reveals papilledema or retinal vascular lesions, medication should be discontinued.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.